PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets | Proceedings of the National Academy of Sciences pnas.org
First patient treated in Clarity's therapeutic pro cancer state trial
Details Category: Proteins and Peptides Published on Saturday, 08 October 2022 12:03 Hits: 122
Clarity…